News Focus
News Focus
icon url

DewDiligence

03/23/18 1:03 PM

#218076 RE: DewDiligence #218067

PTLA is appealing the CHMP's rejection of Betrixaban:

https://finance.yahoo.com/news/portola-pharmaceuticals-receives-plans-appeal-130641159.html

PTLA could prevail with the EMA/CHMP, but I doubt it insofar as they were lucky to get FDA approval for Betrixaban based on a single phase-3 with meh results.